MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD

MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD is a security (CUSIP 61559X104) tracked across SEC portfolio filings. 161 institutional managers reported $1.2B on Form 13F as of 2026-06-30; 9 registered fund positions totaling $20.9M via N-PORT as of 2026-05-31.

Summary

Top institutional holders (Form 13F)

Showing 15 of 161 managers by value.

ManagerLocationValueShares
BVF INC/ILSan Francisco, CA$298.3M16,001,284
Deep Track Capital, LPGREENWICH, CT$119.5M6,408,863
Cormorant Asset Management, LPBOSTON, MA$83.5M4,480,433
JANUS HENDERSON GROUP PLCLONDON, X0$64.3M3,451,628
D. E. Shaw & Co., Inc.New York, NY$44.6M2,390,661
CITADEL ADVISORS LLCMIAMI, FL$38.8M1,323,728
MPM BIOIMPACT LLCBOSTON, MA$33.8M1,811,082
Weiss Asset Management LPBOSTON, MA$31.8M1,708,328
Logos Global Management LPSan Francisco, CA$28.0M1,500,000
Point72 Asset Management, L.P.Stamford, CT$25.5M1,368,518
SUSQUEHANNA INTERNATIONAL GROUP, LLPBALA CYNWYD, PA$22.5M341,424
GOLDMAN SACHS GROUP INCNEW YORK, NY$21.1M1,130,233
TWO SIGMA INVESTMENTS, LPNew York, NY$20.9M1,122,312
Balyasny Asset Management L.P.Chicago, IL$19.9M1,065,610
BlackRock, Inc.New York, NY$19.0M1,021,851

Top fund holders (N-PORT)

FundRegistrantValue% of fund
T. Rowe Price Health Sciences Fund, Inc.T. ROWE PRICE HEALTH SCIENCES FUND, INC.$16.5M15.18%
HARTFORD SMALL CAP GROWTH HLS FUNDHARTFORD HLS SERIES FUND II INC$1.8M22.93%
T. Rowe Price Health Sciences PortfolioT. ROWE PRICE EQUITY SERIES, INC.$1.0M15.21%
Fidelity Nasdaq Composite Index ETFFidelity Commonwealth Trust$589K0.54%
BlackRock Health Sciences Term TrustBlackRock Health Sciences Term Trust$524K5.18%
Victory RS Small Cap Growth Equity VIP SeriesVictory Variable Insurance Funds$211K39.17%
BlackRock Advantage SMID Cap Fund, Inc.BlackRock Advantage SMID Cap Fund, Inc.$127K1.69%
BlackRock Health Sciences TrustBlackRock Health Sciences Trust$110K2.07%
Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Funds$71K0.20%

More